EPA (eicosapentaenoic acid) is an omega-3 fatty acid that plays a central role in controlling inflammation, protecting your cardiovascular system, and supporting mental health. Your body can only make tiny amounts of it on its own, so you rely almost entirely on food or supplements to maintain adequate levels. Its effects reach surprisingly far, from the membranes of your cells to your mood, your joints, and your blood vessels.
How EPA Works Inside Your Cells
EPA gets incorporated directly into the outer membranes of your cells, where it changes how those membranes behave. Cell membranes aren’t just passive wrappers. They contain organized clusters of fats and cholesterol called lipid rafts that serve as signaling platforms, controlling how cells communicate and respond to their environment. When EPA becomes part of these membranes, it increases the size and stability of these rafts, which in turn dials down the activation of certain immune cells.
This matters most for a type of immune cell called CD4+ T cells, which drive many inflammatory responses. EPA disrupts the internal scaffolding these cells need to fully activate, effectively putting a brake on excessive immune reactions. This single mechanism helps explain why EPA has such broad effects across different body systems: it’s influencing inflammation at the cellular level, not just masking symptoms.
Resolving Inflammation, Not Just Reducing It
One of EPA’s most important jobs is producing a family of molecules called E-series resolvins. These are small signaling compounds your body makes from EPA to actively shut down inflammation once it’s done its job. This is different from simply blocking inflammation the way a painkiller does. Resolvins help clear damaged tissue, signal immune cells to stand down, and restore normal function. Four E-series resolvins have been identified so far (RvE1 through RvE4), and they’re part of a broader class of compounds that researchers call specialized pro-resolving mediators.
This resolution process is critical. Chronic diseases like heart disease, arthritis, and diabetes all involve inflammation that never fully switches off. EPA essentially gives your body the raw material to complete that switch-off process.
Cardiovascular Protection
The strongest clinical evidence for EPA involves heart health. In the REDUCE-IT trial, published in the New England Journal of Medicine, patients with elevated triglycerides who took a purified form of EPA (4 grams daily) alongside statin therapy experienced a 25% reduction in major cardiovascular events compared to placebo. That included heart attacks, strokes, and cardiovascular death. The rate of cardiovascular death specifically dropped by 20%.
An earlier Japanese trial of over 18,000 patients found that adding 1.8 grams of EPA daily to statin therapy reduced major coronary events by 19%. These are large, well-designed studies, and the consistency of their findings is part of why EPA has gained attention beyond general omega-3 recommendations.
Mental Health and Depression
EPA appears to be the omega-3 that matters most for mood. A meta-analysis published in Translational Psychiatry found that supplements containing at least 60% EPA at doses of 1 gram per day or less produced meaningful improvements in depression symptoms. Pure EPA formulations and EPA-dominant formulations both showed benefits, while DHA-dominant or pure DHA formulations did not.
The most effective ratio appears to be 2:1 or 3:1 EPA to DHA. This is worth knowing if you’re choosing a supplement, because many fish oil products contain more DHA than EPA, or equal amounts of both. For mood support, the research points toward EPA-heavy formulations. Clinical trials have used EPA doses ranging from 180 mg to 4,000 mg per day, but the clearest benefits cluster around 1 gram or less of EPA daily.
Joint Pain and Arthritis
For people with rheumatoid arthritis, omega-3s containing EPA can reduce morning stiffness, the number of swollen and tender joints, and pain severity. In one 12-week randomized controlled trial, morning stiffness dropped from an average of 128 minutes at baseline to 40 minutes. Analgesic use fell from 25 patients needing pain medication to just 7. Of the patients taking omega-3s, 32% stopped pain medication entirely and another 40% reduced their dose. The placebo group saw no significant change in medication use.
These effects align with EPA’s role in producing resolvins. Joint inflammation in rheumatoid arthritis is a textbook case of the immune system failing to resolve its own response, and EPA helps supply the molecular signals needed to calm that cycle.
Metabolic Health and Blood Sugar
EPA influences how your body handles both fat and sugar. In animal studies of diabetes, EPA treatment improved how fat tissue absorbed and stored fatty acids, while reducing harmful fat oxidation in muscle tissue. These changes were linked to lower circulating insulin levels, suggesting improved insulin sensitivity. EPA also reduced the expression of two key inflammatory signals (TNF-alpha and IL-6) in both muscle and fat tissue.
At the muscle level, EPA increased the expression of a glucose transporter called GLUT4, which helps muscle cells absorb sugar from the bloodstream more efficiently. While the evidence on insulin sensitization is still developing, the anti-inflammatory effects in fat and muscle tissue are well documented and likely contribute to metabolic improvements over time.
Pregnancy: EPA vs. DHA
During pregnancy, both EPA and DHA cross the placenta to reach the developing baby. However, their roles differ significantly. DHA is the dominant omega-3 for fetal brain and eye development, with rapid accumulation in the brain during the last 17 weeks of pregnancy. EPA’s accumulation in the fetal brain, by contrast, is negligible. That doesn’t mean EPA is unimportant during pregnancy, but DHA handles the heavy lifting for neural development. Most prenatal omega-3 recommendations emphasize DHA for this reason, with pregnant women typically advised to get an additional 100 to 200 mg of DHA daily beyond the standard recommendation.
Bleeding Risk: Lower Than You’d Think
A common concern about EPA is that it might thin the blood too much, especially for people on blood thinners. The evidence doesn’t support this. While EPA does have mild antiplatelet effects, clinical data consistently shows it does not increase the risk of significant bleeding. In one surgical study, patients given omega-3s (including EPA) before and after cardiac surgery had no increase in bleeding complications. They actually required fewer blood transfusions than the placebo group, and higher omega-3 levels were associated with lower bleeding risk.
In the REDUCE-IT trial, patients taking 4 grams of EPA daily for years saw a significant reduction in cardiovascular events with no dangerous bleeding signal. One controlled trial comparing EPA and DHA head-to-head found that DHA reduced platelet clumping, but EPA did not significantly affect it at the same dose.
How Much You Need and Where to Get It
The most widely cited recommendation for healthy adults is about 250 mg per day of combined EPA and DHA. Reaching that through food is straightforward if you eat fatty fish a couple of times per week. A 3-ounce serving of farmed Atlantic salmon provides roughly 590 mg of EPA. Wild Atlantic salmon delivers about 350 mg. Sardines contain around 450 mg per 3-ounce serving, and Atlantic mackerel provides about 430 mg.
If you don’t eat fish, algal oil supplements are an option, though most are formulated primarily for DHA and contain variable amounts of EPA, typically in the range of 100 to 300 mg of DHA with smaller amounts of EPA. If you’re looking specifically for EPA (for mood support, for example), check the supplement label for the EPA content rather than just the total omega-3 count. For therapeutic purposes like cardiovascular risk reduction or depression, the doses used in clinical trials (1 to 4 grams of EPA daily) are significantly higher than what most people get from diet alone.